Clinical Trials

Find a Parkview Health Clinical Trial

Search

2 results found

Current Studies

A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physicians Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy

Primary Objective: To compare MK-2870 to Treatment of Physician s Choice (TPC) with respect to progression-free survival (PFS) per RECIST 1.1 as assessed by blinded independent central review (BICR) To compare MK-2870 to TPC with respect to overall survival (OS) Secondary Objectives: To compare...

View Details

Current Studies

A Two-Arm Randomized, Double-Blind, Placebo-Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With HPV16-Positive, PD-L1-positive, Recurrent or Metastatic Cervical Cancer Who Are Refractory to Pembrolizumab With Chemotherapy With/Without Bevacizumab.

Primary Evaluate anti-tumor efficacy of VB10.16 + placebo and VB10.16 + Atezolizumab Secondary Further evaluate anti-tumor efficacy and response durability of VB10.16 + placebo and VB10.16 + atezolizumab Evaluate clinical efficacy of VB10.16 + placebo and VB10.16 + atezolizumab Characterize safety...

View Details